0001209191-17-052873.txt : 20170914
0001209191-17-052873.hdr.sgml : 20170914
20170914193312
ACCESSION NUMBER: 0001209191-17-052873
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170914
FILED AS OF DATE: 20170914
DATE AS OF CHANGE: 20170914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cassidy Bernard J
CENTRAL INDEX KEY: 0001398322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36781
FILM NUMBER: 171086617
MAIL ADDRESS:
STREET 1: C/O TUMBLEWEED COMMUNICATIONS CORP
STREET 2: 700 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Juno Therapeutics, Inc.
CENTRAL INDEX KEY: 0001594864
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463656275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 2065821600
MAIL ADDRESS:
STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-14
0
0001594864
Juno Therapeutics, Inc.
JUNO
0001398322
Cassidy Bernard J
C/O 400 DEXTER AVENUE NORTH
SUITE 1200
SEATTLE
WA
98109
0
1
0
0
General Counsel & Secretary
Common Stock
2017-09-14
4
S
0
23054
44.6656
D
55970
D
Common Stock
2017-09-14
4
S
0
3441
45.9002
D
52529
D
Common Stock
2017-09-14
4
S
0
1505
46.5797
D
51024
D
Common Stock
26869
I
By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 23, 2017.
This transaction was executed in multiple trades at prices ranging from $44.27 to $45.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $45.34 to $46.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $46.38 to $46.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Zachary D. Hale, attorney-in-fact
2017-09-14